More SEC Filings
View Older Stories View Newer Stories-
Form 6-K SK hynix Inc. For: Jul 22
-
Form 424B2 JPMORGAN CHASE & CO
-
Form S-6/A Advisors Disciplined
-
Form EFFECT Our Bond, Inc.
-
Form 425 ENDRA Life Sciences Inc. Filed by: ASP Isotopes Inc.
-
Form EFFECT Lyell Immunopharma, Inc.
-
Form SCHEDULE 13G/A Flywire Corp Filed by: Temasek Holdings (Private) Ltd
-
Form 6-K Banco Santander, S.A. For: Jun 30
-
Form 8-K NEXT-ChemX Corporation. For: Jul 17
-
Form FWP SOUTHERN CALIFORNIA EDIS Filed by: SOUTHERN CALIFORNIA EDISON Co
-
Form 6-K ATA Creativity Global For: Jul 22
-
Form 6-K monday.com Ltd. For: Jul 22
-
Form 6-K SK hynix Inc. For: Jul 22
-
Form 6-K NOMURA HOLDINGS INC For: Jul 22
-
Form EFFECT Outlook Therapeutics,
-
Form EFFECT FREQUENCY ELECTRONICS
-
Form EFFECT NN INC
-
Form 6-K WOODSIDE ENERGY GROUP For: Jul 22
-
Form EFFECT Weatherford Internationa
-
Form EFFECT Bravalo Corp
-
Form EFFECT NewtekOne, Inc.
-
Form EFFECT PDS Biotechnology Corp
-
Form EFFECT HAWTHORN BANCSHARES,
-
Form D/A Tareyton Fund I, L.P.
-
Form 425 Passage BIO, Inc. Filed by: Passage BIO, Inc.
-
Form 424B2 CITIGROUP INC
-
Form FWP ROYAL BANK OF CANADA Filed by: ROYAL BANK OF CANADA
-
Form D Benson Co-investment
-
Form D/A Fund I, a series of Outl
-
Form 13F-HR Lakehouse Capital Pty For: Jun 30
-
Form D Insolent-GO-0613 Fund
-
Form D Mainspring Funding II
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form FWP ROYAL BANK OF CANADA Filed by: ROYAL BANK OF CANADA
-
Form 13F-HR Q Fund Management (Hong For: Jun 30
-
Form N-PX DRIVE WEALTH MANAGEMENT, For: Jun 30
-
Form 424B2 BARCLAYS BANK PLC
-
Form D DHVP SPV V, a series of
-
Form FWP ROYAL BANK OF CANADA Filed by: ROYAL BANK OF CANADA
-
Form C Intelligent Clinical
-
Form 13F-NT Hang Seng Investment For: Jun 30
-
Form 6-K Clinuvel Pharmaceuticals For: Jul 21
-
Form 6-K RedCloud Holdings plc For: Jul 21
-
Form D NE-0312 Fund I, a series
-
Form 13F-HR DRIVE WEALTH MANAGEMENT, For: Jun 30
-
Form 424B2 BARCLAYS BANK PLC
-
Form D MA-0501 Fund I, a series
-
Form FWP GS Finance Corp. Filed by: GS Finance Corp.
-
Form 6-K Clinuvel Pharmaceuticals For: Jul 21
-
Form N-PX Xena Financial Planning, For: Jun 30

